An experience of sequental use of three biologics and recombinant growth hormone in a patient with juvenile idiopathic arthritis associated with unsuccessful outcome of hip damage

Lignende værker

• PReS-FINAL-2076: Single centre experience of biologics in clinical practice of systemic juvenile idiopatic arthritis
  af: Kaleda, MI, et al.
  Udgivet: (2013)
• Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy
  af: Nikishina, I, et al.
  Udgivet: (2008)
• INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS
  af: I.P. Nikishina, et al.
  Udgivet: (2010-01-01)
• Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
  af: Kaleda, Maria I, et al.
  Udgivet: (2014)
• PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice
  af: Arsenyeva, SV, et al.
  Udgivet: (2013)